Position in HIMS
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$138
-$152 QoQ
Shares Held
4
-66.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#501
of 504 holders
Holding Since
Dec 2024
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Abound Wealth Management holds $8,320 across 10 Drug Manufacturers - Specialty & Generic names. HIMS ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
172 | $2,731 | |
| 2 | ZTS |
Zoetis Inc.
|
31 | $2,227 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
74 | $1,821 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
36 | $521 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
6 | $246 | |
| 6 | LQDA |
Liquidia Corp
|
3 | $239 | |
| 7 | ALKS |
Alkermes plc.
|
4 | $209 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
This page
|
4 | $138 |
All Filings in HIMS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $138 | 4 | Shares | Sole | 2026-07-10 | |
| 2024-12-31 | $290 | 12 | Shares | Sole | 2025-01-13 | |
| No filing history on record for this holder in this stock. | ||||||